Ultraphonophoresis with a hyaluronic acid-containing gel for knee osteoarthritis with periarthritis

Management of patients with knee osteoarthritis (OA) in the presence of comorbidity causes significant difficulties associated with the limitations of pharmacotherapy.

Objective: to evaluate the clinical efficacy of ultraphonophoresis with a hyaluronic acid (HA)-containing gel in patients with knee OA complicated by periarthritis.

Patients and methods. The open observational comparative study included 30 patients with a reliable diagnosis of knee OA, who were divided into two groups: 1) 15 patients who had undergone ultraphonophoresis with a HA-containing gel for 10 days (a study group); 2) 15 patients who had received ultraphonophoresis with an intact gel (a control group). To determine the clinical efficiency of HA-containing gel ultraphonophoresis, the investigators conducted a survey of patients and a clinical examination with knee joint palpation to detect synovitis and periarthritis, ultrasonography, and an assessment of initial pain and pain on walking on a 100-mm visual analog scale (VAS) for pain.

Results and discussion. HA-containing gel ultraphonophoresis was found to lead to a significant relief from both pain in the knee joints on walking from 50 [40; 50] to 20 [10; 20] mm (p = 0.0003) and from initial pain from 50 [40; 50] to 10 [0; 10] mm VAS (p = 0.0003). Ultrasonography revealed a reduction or even complete disappearance of the local inflammatory process in the anserine bursa from 5.5 [4.5; 6.4] to 0 [0; 3.0] mm (p = 0.0003). There were no statistically significant pre- and postoperative differences in Group 2 patients.

Conclusion. HA-containing gel ultraphonophoresis in knee OA with periarthritis was shown to contribute to a significant reduction in knee joint pain and to the resolution of periarthritis.

Management of patients with knee osteoarthritis (OA) in the presence of comorbidity causes significant difficulties associated with the limitations of pharmacotherapy.Objective: to evaluate the clinical efficacy of ultraphonophoresis with a hyaluronic acid (HA)-containing gel in patients with knee OA complicated by periarthritis.Patients and methods. The open observational comparative study included 30 patients with a reliable diagnosis of knee OA, who were divided into two groups: 1) 15 patients who had undergone ultraphonophoresis with a HA-containing gel for 10 days (a study group); 2) 15 patients who had received ultraphonophoresis with an intact gel (a control group). To determine the clinical efficiency of HA-containing gel ultraphonophoresis, the investigators conducted a survey of patients and a clinical examination with knee joint palpation to detect synovitis and periarthritis, ultrasonography, and an assessment of initial pain and pain on walking on a 100-mm visual analog scale (VAS) for pain.Results and discussion. HA-containing gel ultraphonophoresis was found to lead to a significant relief from both pain in the knee joints on walking from 50 [40; 50] to 20 [10; 20] mm (p = 0.0003) and from initial pain from 50 [40; 50] to 10 [0; 10] mm VAS (p = 0.0003). Ultrasonography revealed a reduction or even complete disappearance of the local inflammatory process in the anserine bursa from 5.5 [4.5; 6.4] to 0 [0; 3.0] mm (p = 0.0003). There were no statistically significant pre- and postoperative differences in Group 2 patients.Conclusion. HA-containing gel ultraphonophoresis in knee OA with periarthritis was shown to contribute to a significant reduction in knee joint pain and to the resolution of periarthritis.

hyaluronic acid, osteoarthritis, ultraphonophoresis, hyaluronic acid-containing gel, physiotherapy, inflammatory process in the anserine bursa

1. Karateev AE, Lila AM. Osteoarthritis: current clinical concept and some promising therapeutic approaches. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2018;56(1):70-81. (In Russ.). doi: 10.14412/1995-4484-2018-70-81

2. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012 Dec 15;380(9859):2163-96. doi: 10.1016/S0140-6736(12)61729-2.

3. Palazzo C, Ravaud JF, Papelard A, et al. The burden of musculoskeletal conditions. PLoS One. 2014 Mar 4;9(3):e90633. doi: 10.1371/journal.pone.0090633. eCollection 2014.

4. Martel-Pelletier J, Barr AJ, Cicuttini FM, et al. Osteoarthritis. Nat Rev Dis Primers. 2016 Oct 13;2:16072. doi: 10.1038/nrdp.2016.72.

5. Palazzo C, Nguyen C, Lefevre-Colau MM, et al. Risk factors and burden of osteoarthritis. Ann Phys Rehabil Med. 2016 Jun;59(3): 134-8. doi: 10.1016/j.rehab.2016.01.006.

6. Balabanova RM, Dubinina TV, Demina AV, Krichevskaya OA. The incidence of musculoskeletal diseases in the Russian Federation over 2015-2016. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2018;56(1):15-21. (In Russ.) doi: 10.14412/1995-4484-2018-15-21

7. Petrun'ko IL, Men'shikova LV. Osteoarthritis: disability in persons of working age in the Irkutsk region. Sibirskij medicinskij zurnal (Irkutsk). 2009; (7):204-6. (In Russ.)

8. Ankudinov AS. Problems of cardiovascular comorbidity in osteoarthritis. Sovremennye problemy revmatologii. 2013; 5(5):22-31. (In Russ.)

9. Trifonova EP, Zonova EV, Sazonova OV. Clinical and immunological features of patients with osteoarthritis in combination with obesity, metabolic syndrome and type 2 diabetes mellitus. Sibirskij medicinskij zurnal (Irkutsk). 2017;(1):5-11. (In Russ.).

10. Ankudinov AS, Kalyagin AN. Immunomodulatory cytokines in chronic heart failure associated with knee osteoarthritis. Sibirskij medicinskij zurnal (Irkutsk). 2015;(6):109-12. (In Russ.).

11. McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014 Mar;22(3):363-88. doi: 10.1016/j.joca.2014.01.003. Epub 2014 Jan 24.

12. Alekseeva LI, Naumov AV. The management of osteoarthritis with comorbidity in General medical practice (clinical guidelines). Doctor.Ru. 2017;(5):51-69. (In Russ.).

13. Nasonov EL, Yakhno NN, Karateev AE, et al. General principles of treatment for musculoskeletal pain: interdisciplinary consensus. Nauchnoprakticheskaya revmatologiya = Rheumatology Science and Practice. 2016;54(3):247-65. (In Russ.). doi: 10.14412/1995-4484-2016-247-265

14. Ponomarenko GN, editor. Fizicheskaya i reabilitatsionnaya meditsina: natsional'noe rukovodstvo [Physical and rehabilitation medicine: the national guide]. Moscow: GEOTAR-Media; 2016. P. 344-9.

15. Chichasova NV, Imametdinova GR. The 2014 guidelines for the management of osteoarthritis: Place of hyaluronic acid preparations. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2015;9(4):37-43. (In Russ.). doi:10.14412/1996-7012-2015-4-37-43

16. Anikin SG, Alekseeva LI. Use of hyaluronic acid preparations for knee osteoarthrosis. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2013;51(4):439–45. (In Russ.). doi:10.14412/1995-4484-2013-1257

17. Olyunin YuA. Use of hyaluronic acid preparations in the combination therapy of osteoarthritis. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2016;10(2):64-9. (In Russ.). doi:10.14412/1996-7012-2016-2-64-69

18. Balabanova RM. Place of hyaluronic acid preparations in therapy for osteoarthrosis. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2014;8(3): 73-6. (In Russ.). doi:10.14412/1996-7012-2014-3-73-76

19. Strakhov MA, Skoroglyadov AB, Kostiv IM, et al. The use of low molecular weight drugs of linked hyaluronic acid in athletes with extra-articular pain localization. Poliklinika. 2013;(2-1):54-60. (In Russ.)

20. Farooq MA, Devitt AT. Perceived efficacy and risks of infection following intra-articular injections: a survey of orthopaedic surgeons. Ir J Med Sci. 2005 Jan-Mar;174(1):26-32. doi: 10.1007/BF03168515

21. Charalambous C, Tryfonidis M, Sadiq S, et al. Septic arthritis following intraarticular glucocorticoid injection of the knee – a survey of current practice regarding antiseptic technique used during intra-articular glucocorticoid injection of the knee. Clin Rheumatol. 2003 Dec;22(6):386-90. Epub 2003 Oct 15. doi: 10.1007/s10067-003-0757-7

22. Debbi EM, Agar G, Fichman G, et al. Efficacy of methylsulfonylmethane supplementation on osteoarthritis of the knee: a randomized controlled study. BMC Complement Altern Med. 2011 Jun 27;11:50. doi: 10.1186/1472-6882-11-50.

23. Cameron M, Chrubasik S. Topical herbal therapies for treating osteoarthritis. Cochrane Database Syst Rev. 2013;(5):CD010538. doi: 10.1002/14651858.CD010538.

24. Mozaffari-Khosravi H, Naderi Z, Dehghan A, et al. Effect of Ginger Supplementation on Proinflammatory Cytokines in Older Patients with Osteoarthritis: Outcomes of a Randomized Controlled Clinical Trial. J Nutr Gerontol Geriatr. 2016;35(3):209-18. doi: 10.1080/21551197.2016.1206762.

25. Grube B, Gr?nwald J, Krug L, Staiger C. Efficacy of a comfrey root (Symphyti offic. radix) extract ointment in the treatment of patients with painful osteoarthritis of the knee: results of a double-blind, randomised, bicenter, placebo-controlled trial. Phytomedicine. 2007 Jan;14(1):2-10. Epub 2006 Dec 13.

26. Jä ger C, Hrenn A, Zwingmann J, et al. Phytomedicines prepared from Arnica flowers inhibit the transcription factors AP-1 and NF-kappaB and modulate the activity of MMP1 and MMP13 in human and bovine chondrocytes. Planta Med. 2009;75(12): 1319-25. doi: 10.1055/s-0029-1185668. Epub 2009 May 8.

27. Altman RD. Criteria for classification of clinical osteoarthritis. J Rheumatol Suppl. 1991 Feb;27:10-2. 28. Kellgren JH, Lowrence JS. Radiological assessment of osteoarthritis. Ann Rheum Dis. 1957;16(4):494-502.

28. Abramovich SG, Kirgizova OYu. Fonoforez lekarstvennykh veshchestv [Phonophoresis of medicinal substances]. Irkutsk; 2002. 15 p.

29. Khar'kova OA, Grzhibovskii AM. Comparison of two paired samples with the statistical software package STATA: nonparametric tests. Ekologiya cheloveka. 2014;(12):55-60. (In Russ.)

30. Avdeeva OS. General approaches to the use of restorative medicine in the treatment of osteoarthritis. Klinicheskaya meditsina i farmakologiya. 2015; (3):11-27. (In Russ.)

31. Shepetova ON, Novikov AV. Phonophoresis with «Chondroxid» oinment efficacy in treatment of pts with osteoarthritis. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2004;(2):9. (In Russ.).

32. Antipova OV, Kalyagin AN, Golova NI, et al. The use of Phastum-gel phonophoresis in diseases of soft tissues. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2002; (4): 74. (In Russ.).

33. Rushai AK, Klimovitskii VG, Bogdanova LV, et al. Physiotherapy rehabilitation of patients with lesions of the lower leg and ankle using drugs Fastum gel® and lioton gel®. Travma. 2015;16(1):45-9. (In Russ.)

34. Souza J, Meira A, Volpato NM, Mayorga P, Gottfried C. Effect of phonophoresis on skin permeation of commercial anti-inflammatory gels: sodium diclofenac and ketoprofen. Ultrasound Med Biol. 2013;39(9):1623-30. doi: 10.1016/j.ultrasmedbio.2013.02.009.

35. Tereshina LG, Shirokov VA, Leiderman EL, Kuznetsova TG. New methods of drug phonophoresis in the treatment of patients with osteoarthritis, working in physical overload. Meditsina truda i promyshlennaya ekologiya. 2007;(3):39-42. (In Russ.).

36. Nakhostin-Roohi B, Khoshkhahesh F, Bohlooli S. Effect of virgin olive oil versus piroxicam phonophoresis on exerciseinduced anterior knee pain. Avicenna J Phytomed. 2016;6(5):535-541.

37. Rafanan BS Jr, Valdecanas BF, Lim BP, Malairungsakul A, Tassanawipas W, Shiyi C, Tse LF, Luong TK. Consensus recommendations for managing osteoarthritic pain with topical NSAIDs in Asia-Pacific. Pain Manag. 2018;8(2):115-128. doi: 10.2217/pmt-2017-0047.